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Effect of Intervention to Reduce Long-Term 
Myocardial Ischemla 
Tuesday, March 31, 1998, 4:00 p.m.-5:30 p.m, 
Georgia World Congress Canter, Room 364W 
4:00 
~ Clinical Results and Ravasrularlzatlon Status Five 
Yearn Following Randomization to PTCA or CABG In 
Bypass Angioplasty Rsvasautarizatlon Invastigatton 
(BARi) 
E,L, AldOnllan, M,G, Bouraeeo. P,L, Whitlow, R,M Cellfl. L, Schwndz, 
K,E, Kip, Sfan~ord Unlv~r~t~ Sh1,~o~d, CA; Unlvfl~ify of Pittsburgh. 
PIf~b~th, PA, USA 
~ckgmtfftd & M~fho(l~: Out el a consecutive series of 612 patients (pie) 
at 4 Of 18 clinical eltm~, 407 (79%) h{Id 5 yr followup anglography to relate 
anglogmphle disease to cllnt~et ot~tcomo, Compared with the other 1208 
elm/lying DIS tn eARl, 5 yr ~nglo pts wore younger, had less 3 veseot d sease 
with fewer toter o~duaione and had better LV function with tess CHF, Pie 
h~vlng PTCA or CADG wore etmil,~r, wttlr 34% having 3 vessel disease (3,3 
lesions ~SO%/pt) ~nd 00,1% mesn jeepardi,~od myo~rdi~tm (MyoJ6p) p0r 
pt, e~tlmA~od aa % el LV t(~rrltory distal to :~BO% lesions, 
R~utt~: For 202 PTCA tw~ted pts, thaw wore 232 tniti~t procedures 
attempting ~,(~ teeton~tpt will 8~% Iltltlal teslOll etlccees (, 50%), el those 
pt~, 5~,5% had ~0dltlon,~l procedures (PTGA: 39~%; CAge: 20,1~%1, el  a~1 
5~2 Initial and 59 incremental ttempted lestons/pt, 78,8% warn .~50% at 5 
ym, An~ong pt~ with inttloily eu¢cesMut PTCA ( ~: 1 lesion successfully treated), 
41% wqulmd mtmotment by PTCA or CABG, For 200 CAge treated pts, 
them warn no additional CABGe and 17 PTCAs, Of 334 vein grafts restudied. 
87% w~m I~tent and 84% warn free o! lesions :~ 50%, el 198 mammary grafts 
mstu~lled, 95% wow patent and 8~% were two of lesions :50%, MyoJop fell 
from 60,1% to 19,5% at B yrs in CABG pta and to 24,B% in PTCA pts (p .: 
0,01), Of 289 pta with MyoJep ~:33% at 5 yrs, 20.4% el PTCA pts ve, 172% 
oi CABG pie had angina (NS), Ot 115 pts w(th MyoJop .33%, 41,4%, of 
PTCA pta v~, 22,9% of CABG pt~ h~d nnglna (p =, 0,05), RegreSsion analysts 
showed ~ yr MyOJep, revere angina at entn/nnd smoktng history m r~nk 
ord0r to be associated with angina at 5 yr~, 
Gonclu.~on: For pta sun~Mng S yrs, CAaG yielded 92 percentage points 
legs anglos 1hen PTCA, a result consistent with the 5,3 percentage point 
dlffewn¢a in MyoJop, 
4:15 
~ Results of the Multlcsnter Study of Enhanced 
Externsl Counterpulsatlon (MUST-EECP): Clinical 
Benefits am Sustained at a Mean Follow-up TIm~ of 
One Year 
R, Arora, T, Cho~.l, O, Join, R. Nesto, B, Flolshman, L. Crnwford, 
I', McKteman, For the MUST-EECP invosti,(~tors: Columbia Univemi~ New 
Yor~. USA 
Background: In May 1997 enrollment concluded in the first national, multi- 
center, wndomi;red, placebo.controlled trial at enhanced external cajoler- 
pulsation (EPCP), a non-invasive therapy for pts with coronary artery msease 
(CAD) an~t chronic angina poetess rAP), 
Methods: Between 1995 and 1997, 139 pts were enrolled (mean age 63, 
range 35-81 yrs), 57% had corona~' artery bypass surgery nn~or angio- 
plesty, 49% had prior myocardial infarctions, 74% wow in Canadian (,:lass 2 
or 3, and 56% had "residual" muttivessot CAD despite mvasculadzation. Pts 
wow randomized to active counterpulsation (AC) or inactive (sham) coun- 
terpulsation (tC) for 35 hrs of outpatient h6~py over a 4-7 week period, 
Pro- and post-counterputsatton EX tests and first-and-last week anginal di- 
ones wow analyzed in a blinded fashion, Ll~tng mail and telephone follow.up 
procedures, 80 pts who were at toast 3 rues post treatment were contacted. 
Results: Baseline clinical end angiographic haracteristics were similar in 
the AC and IC groups, AC resulted in a significant increase in EX duration 
and in time to onset at ischemic ST depression and a decrease in v,~ekly 
anginal episodes. IC resulted only in increased EX duration. No sedous 
complications occurred in either the AC or IC groups. Eighty patients were 
contacted during the followup period, 40 in each group. Mean followup time 
was 11.7 and t 2. I rues respectively (pNS) with a mean followup of 11.9 rues 
for the total group. Hospitalization rates for both groups were not significantly 
different (9/40 vs 5/40) but improvement in symptoms was more significant 
in the AC group (25/40 vs. 15/40, p < 0,01). 
Conclusion,. In addition to significant immediate improvement inischemic 
parameters, beneficial clinical effects were present 1 yr after treatment in 
70% of pts undergoing EECP. 
4:30 
~5~7 Pemutaneuu8 Myocardial Ravescularlzatlon, a New 
Approach to Patients With Intractable Angina 
Pectorla 
B, Louer, U, Junghana, F, Stahl. E. Bmnnan. S, ecstatic, G. Schulor. H~rt 
Center, Leipzig, Germany: Stanford Univemtl~, Pato Alto, CA, USA 
Backgw~Jnd: Transmyo~ardial l mer mvasculerizatlon (TMLR) in I~tienta with 
~ownary adery disease and untmctabte angina ~otoris is associated with 
considerable porloperntive morbidity en¢l mortality, Therefore, a catheter- 
based system was developed for laser mvaseula,~atlon el the myocardiam 
from the lelt ventric;glar cavity, 
Methad~: 16 Patients (P) (64,3 -~ 5,7 years) with ~v~m coronary mle~ 
disease not omenable to bypass grafting or comnaq/anoJopla~ty w~m l~Wd 
with per~utaneoue myoc~a~lal rsva~culffrilatian (PMR), Seintigraph¢ evt. 
den(~e of ischomla was demonstrated in the anterior wall in 10 P. in the latem! 
well in 5 P sad in the inferior waft in 4 P (t P had isehemi~ in the antenor and 
the inter(at wa~L), 
R~stdt~: PMR wa~ su~essfu!ly pelfom~d in all P- 1!,8 :~ 3,0 (?~1 S) laser 
channels wow t;m~tod per raglan tm~ted, Cmatine kin~se levels rose from 
72 1- 21 U/I to 158 ~ 40 U/L Minor advemo effects w~o a nOn,Sustai~ 
vontricolar tachygffrdi~l in 1 P end a sma!l peri(,',a~dial eltusion (2 ram) in 
t P detected by ~hoCmdiegwphy not mqumng drainage, Alter 3 monlh~, 
Canadlnn Cardiologie Society • (:lass had improved 1 or 2 classes in 6/? P 
Exomise time on biQycte XOK:iSe test in~reasod from 6.0 ± 40 to 87 -~ 4.5 
mln (not significant), SQtntigraphieally, 14/28 ventnoutar s~ments twated 
with PMR llad improved podustoa, 3 segments had detenorated and 11 
so~monts were unchanged, 
ConcluaiOK PMR is ~ s~fe and feasible technique. Thaw were no serious 
complications tn the tirol IF'. PMR seems to wleave angina parians stmdar to 
TMLR, pmliminan/data suggosl a 1mad towards incwased exercise capacity 
and improved tog, tonal pe~usion. 
4:45 
~ Corrolatea of Celiac Death Early After Hospital 
Discharge in Patients who Have Undergone 
Parcutaneoue 11"eatment of Unprotecled Left Main 
Stenosea - What Am the Lessons? 
S. Ellis, M, Nobuyoshi, H. Tamer, 1. Plokker, S.-J. Park. T. Suzuki. Cleveland 
Clinic Founclahon, Cleveland OH. USA 
Concern has been raised about the risk of early (:~ 9 rues) cardiac death IECD) 
after patient (pt) discharge from hospital after percutaneous rx o1 unprotected 
leri main stenoses (ULMS). To evaluate the inc|dence and correlates of ECD 
we quened a registn/of 262 consecutively treated pts Item 25 centers rx'd 
since 1/94. Pts with definite non-cardiac ause !of death were excluded In 
= 4). 9% of pts had ECD (6 MI including = slant thrombosis. 4 sudden. 2 
during rx o! rostonosis. 4 other). Odds ratios (OR) for correlates el ECD troth 
univariate p .: 0.10 arO shown. 
Unlvanato O~ Mutt,vanate OR P value 
LVEF !30% 1244 17.09 0 001" 
Nat CABG candidate 1050 
Croattnmo :2 rag% 4.46 
Poor bypass urgery 3.02 
Rest/progrosswo angina 3 09 4.26 0.028" 
OCA - 069 065 
Slant O 72 062 
PTCA 3.54 O.13 
Age, diabetes, lesion morphology, post-rx %stenosis and T~clopidine use 
had p :: 0,10. Pts with ~ 1 nsk factors (') and stent or DCA had ECD = 15%, 
with neither ECD = 3,2%. ECD alter percutaneous ULMS rx remains fairly 
common, difficult o prechct, and the primary reason to be cautious about 
percutaneous rx of ULMS. 
5:00 
[85~ Has the Prognosis for Left Main (LM) and Left Main 
Equivalent (LMEQ) Coronary Disesse Changed: 
Analysis o! ~ Long Waiting List 
J.M. Elliott, N.W. Jackson, M.P. Doogue, O.W. Smyth. Christchurch 
Hospital. Christchurch, New Zealand 
Background: The long waiting times for coronary bypass surgery (CABG) 
in New Zealand enab!e analysis of outcomes on medical therapy in patient 
groups that receive early CABG in other countries. 
Methods: We have reviewed clinical characteristics at referral and out- 
comes while waiting in 412 consecutive patients referred from our institution 
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for isolated CABG between July 1 1993 end Do<: 31 1995. Patients were 
censored from follow-up at the time of CABG. 
Results: 101 patients had >~ 50% LM st~tosls (by QCA) and 103 had 
LMEQ disease, Med,an age was 66 (57-69, tO range) and 64 (57-69) years, 
2S aM 34 W~r~ won, t(m, 43 and 40 had Class IV angina, and m~llan w~its for 
CABG were 64 (12-=215) ~nd 95 (21-365) d~y~ in th~ LM and LMEQ groups. 
Freedom from de~th at 1 year w~ 0,79 in fill LM ar¢l 0+94 in LM patients 
wt~ Clan I-Ill angin,m ot mistral, find 0,98 and 0,96 in e~¢h LMEQ group, 
Them ~ frequ~mt readmms~n~, ~t.~ly with unstable angif~; freedom 
from death, MI or f~ssmn w~ 0,46 and 0,53 in t l~ LM and LMEQ 
0rou0s, 
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Co~"~SeO~S: ~wal  m pa~e~s ~ LM oe LMEQ ~sease may de 
heifer m the I~°S  than in the tgT0*s ~ madm~ssmn is frequent+ resource 
u~t,mal~n is~.  and po~ent~y peevemable deaths oo~+'+ 
5:15 
Pat Je~t , ,Phy~~ ~ ~ t  on 
CaRflovas~W Risk FaClOf Mana~ 
S. More, R.S. S~fford, R.E+ C '~ T I~shOp, R+C Pastemal~ 
A~, ~ - - ~  C .~ Hoste l  ~ .  MA. USA 
Effoclwe ~ f~c1~r (RF) management ¢~-,-,ds on rer~l~fe common~catmn 
I ~  an~ pat~mts (l~S)+ We m~=sl~ated levels el co~cor- 
dano~ ~ ptS. I ~  a.,¢l 8~e medmal record f~" selected RF 
acthntJes. 
Me~ods: A ~oss-sectmnal ~ of 234 pts rn a cammk~y prachce 
composed of 28 ca,K~kokx~'ts was u~dedake~. ~ inte~'~ with pts 
were ce~bcled 3-7 ~ alter the mint t~ommtmn Imm p~ a~ Pr,~mmms 
was compared t+mth documeetatmn m the med+cal recoKl for blood Im'essure 
(eP) values, choleslerol leslmg, diet assessment and diel cotmselmg. 
Resu/~: BP measurements were rel~led by 99% of phys:oans, 97% of 
pts. and 94% of me<f~cal records. Cholesterol tsslmg was reported by 19% of 
phys~ctans. 13% of pts. and 15% ol mescal records. D~et assessments were 
repoded by 74% ol physicians, 51% of pts, and 43% of mescal records. 
Diet oDuRse|in 0 was repof1~ by 5~@o Of 13~P3fcIa~s, 3~,  Ot pts, and 24% 
of medical reco~3s. Pts' recap of systolic and diastohc BP measurements 
correlated strongly ~ actual values (conelatJon coeffpc~ems 0.96 and 09t.  
p < 0.001; mean systol¢ BP d~ffere~ce 1.8, SD 4.6. 
Conclusion: Pt-phys~cian-medral record agreement on RF mtenmntmns 
dudng visits was strO~J for BP and cholesterol. Compared ~ patient ar~l 
medral record documentation, physicians over.reported d~et interventm~s, 
suggesting that dtfterent baseline RFs influe~¢'e comrmtn~cation a d docu- 
mentatmn of RF lnte~vent~ns. 
Ischemic Complications of Coronary 
Interventions 
Tuesday, March 31, 1998, 4:00 p.m.-5:30 p.m. 
Georgia World Congress Center, Lecture Hall 1 
4:00 
~ Lack of Association of Intermediate CPK-MB 
Elevation and Late Mortality in Patients l~eated With 
intracoronary Steels 
J,F. Saucedo, J.J. Popma, R. Mehran, T. Bucher, A.S. Abizaid, M Curran. 
M. Mastoor, K.M Kent, A. Pichard, L Satter, MB. Leon. Washington 
Hospital Center, Washington. D.C., USA 
We have previously reported an association between intermediate level 
CK-MB elevation and late mortality a~ter atheroablative new device angio- 
plasty. To determine whether this association is also present in pts undergoing 
steel placement, we reviewed the late clinical outcome of 900 consecutive 
pts (1213 lesions) undergoing successful stenting in native vessels. Postpro- 
cedu~ CK-MB were normal (N) in 65%° 1-5 × N in 26% and >5 x N in 8% 
el pts. Although late mortality was h~gher m most pts w~th CK-MB ~5 . N. 
no assoclallon was found l~11N6en interm4~ialo lavIH CK-MB ekP, titlon 
late moffality. (Table}. 
Norm~iN = 5~5 -I-~ • Nn=~38 05 . Nn = T'/ 
Oe~l~, % 1 ? 12 09" 
MI, % 10 UI~ 4.1" 
CAOG, % 6 2 ~.8 # 3 
IPTCA, % t9 0 14 1 ;23~ 
Tt.R (C~,~PIC~}, % t(~ s ~5.t t0 t 
+p. 005, "p ,  00t companng ~ normal CK.M0 (]m~p 
Mid1~anat~ analysis also ~howe~ and il~mase nsk for MACE in me 
highest CK+M5 group (RR: 1,79, p ,~ 005) but not in the i m ~  
CK+MB group (p ~ 0~), 
We ~ude;  t) In teState  CK.MI3 ek~almnp are frequent allor com- 
naqt slenting (26%), and 2) am not assocm~ w~ late motlal~ or Clin~al 
events. 
4:15 
. . . . . .  Coronary Imewem!on Wltlt Dlffemm I : lev~ 
SK S~am'~ A~ Kini, S. Kms, R Vtdhm'L G, Oangas, S Duwun, TP Cooke, 
JD. Marmur, JA  Ambrose. Mount. Sm~ Hoa¢,dat, N~, US4 
Creatine Kmase-MB (CK-MB) e~vm~:m has ~ shown to occur after suc- 
ceasful mlervent~ and is a ~red¢~or of late cardiac events, MI and dealh. 
Prerm~na~y reports I~ave revealed higher CK-MB elevation after newer dle- 
t~:es tO) su~ as n~z~nal at/~reCtomy (RA), steel directional aff~eractomy 
(DCA), translummal exlmclmnal catheter ~C) ,  ~;m-.pared to balloon ang~o- 
plasty (PTCA). We ralx~ the ~ of CK-MB enzyme ek~valmn w~min 
24 hrs of intervan~on m 842 consectdl~e palmers in relation Io (~flerent 
~3es of t~m~,~o~+ Pat~n~ ~ ~ MI (38), Uroklnase mlumon (a) 
~r elevated pm~m:edumt CK-MB (10). were e ~ .  Procedural success 
(<50% dram. ~ post procedure) was gS-L'L~O, and ma~or compli- 
c~ions of acute closure, st~acute ~ m~is ,  Q-wave MI, eme~mll 
CABG, or ~ 1  dea~ occurred in 6 pa~ents (0.7%)+ 
Resu/~. Overa~ ~-~e of any CK-MB elevation was t5,7%, and was 
not d~=,,~; after sm~te vessel versus multipte vessel mtervenhon CK-M~ 
m vanOus demoBs: 
CK-IV~ ~CA RA 'STeel DCA TEC C, om~ne~ D
n=IS5 n=23~ n=232 n=2S n=20 1"+=222 
.~ly rise 6P+ 143%" 168%" 2C~=" L:~'~" 194%" 
I -3X 4 S% 10 ~'o 1Q 8'% ~ IP'~ 15~'% 
3-5X 0 I 3'% 3 4% 0 5% 36% 
-SX t S% 2 ~% 26% O 5% 05% 
• p - 0 005 vS PTCA There was a Prer~ toward lower CK JU5 etevat~n after RA alone vs 
~'a~t alone (p - 0 0"I) (~"Jt~e me mmla~ ReoPto 'JsP ('~P';" RA, 2<J% In slenl P = NS) 
Conclusions: CK-MB e~evatmn is more frequent after new devce inter- 
ven~ons compared to FTCA. CeoWa W to pnor data, RA was not assomated 
w~h a hggher mcm'~ice of CK-MB elevalm~ compared to the stem =,lone+ Tills 
m~J be due tO ~ t s  in RA techmque and a slightly higher inodenc~ 
of s~de branch occlusion in the sleet group, 
4:30 
~'~ Does the Magnitude of Cm~ne KinaR E .levatio.n 
Impact Survival in Non-O My~,cardlal Intarclmn An~r 
Coronary Interventions? 
Z. Ghazzal. P. ChalasanL Y. Shah, N. Chronos, S.B, King, Ill+ 
W.S Weintmub. Emery Unn,ers~ty Atlanta. GA. USA 
Etevatmns of creatinine ktnase (CK) after angioplasty has been shown to 
have an adverse outcome. In this StUdy we focused on the relation of the 
magn=tude c t CK elevation to survnraL Patients who undenNent angmplasty 
were dMded into four groups: Group I (CK <250 mg/dl: n = 14034); Group It 
(,CK 250-500 mg/dl; n = 6740), Group Ill (CK 500-750 mg/dl: n = 185); Group 
IV (CK >750 mg/d[). Patients wdh Q wave Mls compficating angiuplasty 
were excluded, Sunnval was not decreased until CK was above 500 mg/dl 
(left figure). The increased mortality related to CK elevation was limited to 
patients having vein graft procedures (right figure). CK elevation >750 mg/dl 
was noted in 3.7% of vein graft procedures vs 2.6% of cf native vessel 
procedures ~p = 0.02). CK elevation was much more common in patients 
with procedural complications (acute closure, side branch closure or distal 
embOlization (19%) vs an uncomplicated procedure (0.27%. p < 0.0001). 
Conclusions: 1. E!evation of CK post PTCA above 500 mg/dl has a neg- 
ative impact on suwival, but only in patients with vein graft procedures. 
